The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,296.00
Bid: 12,322.00
Ask: 12,324.00
Change: -108.00 (-0.87%)
Spread: 2.00 (0.016%)
Open: 12,334.00
High: 12,362.00
Low: 12,250.00
Prev. Close: 12,404.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 8-UK rolls out AstraZeneca shots but PM Johnson poised to tighten restrictions

Mon, 04th Jan 2021 07:57

* UK first to roll out AstraZeneca vaccine

* PM Johnson set to announce tougher restrictions

* 82-year-old dialysis patient is first to get shot

* UK hails British scientific 'triumph'

* Concerns grow over South African variant
(Combines stories)

By Alistair Smout and Guy Faulconbridge

LONDON, Jan 4 (Reuters) - Britain became the first country
to vaccinate its population with Oxford University and
AstraZeneca's COVID-19 shot on Monday, but Prime
Minister Boris Johnson was set to tighten restrictions in
England in an bid to slow the spread of cases.

Johnson will make a televised address at 8 p.m. (2000 GMT)
and parliament will be recalled on Wednesday.

"The spread of the new variant of COVID-19 has led to
rapidly escalating case numbers across the country," a spokesman
from the prime minister's office said.

"The prime minister is clear that further steps must now be
taken to arrest this rise and to protect the NHS (National
Health Service) and save lives. He will set those out this
evening."

Against the ominous backdrop of record daily cases, Britain
touted a scientific "triumph" as dialysis patient Brian Pinker,
82, became the first person to get the Oxford/AstraZeneca shot
outside of a trial.

"I am so pleased to be getting the COVID vaccine today and
really proud that it is one that was invented in Oxford," said
Pinker, a retired maintenance manager, just a few hundred metres
from where the vaccine was developed.

Britain is grappling with the world's sixth highest death
toll and one of the worst economic hits from the COVID-19
crisis. More than 75,000 people in the United Kingdom have died
from COVID-19 within 28 days of a positive test.

It was the first country to roll out the vaccine developed
by Pfizer and Germany's BioNTech almost a
month ago, and is prioritising getting a first dose of vaccines
to as many people as possible over giving second doses.

Some experts say they are worried about such an approach.

Two new variants of the coronavirus are complicating the
COVID-19 response and Britain has seen a resurgence in cases to
new daily highs.

UK scientists have expressed concern that COVID-19 vaccines
being rolled out may not be able to protect against a new
variant of the coronavirus that emerged in South Africa and has
spread internationally.

Johnson warned of "tough, tough weeks" ahead.

"If you look at the numbers, there's no question that we're
going to have to take tougher measures," Johnson said on a visit
to see health workers receiving the Oxford vaccine.

RESTRICTIONS GETTING TOUGHER

ITV News said the toughest Tier 4 level of restrictions,
which currently cover much of England, will be imposed across
the country and schools would be closed.

Moving ahead of Johnson, Scottish First Minister Nicola
Sturgeon imposed the most stringent lockdown since last spring.

"It is no exaggeration to say that I am more concerned about
the situation that we face now than I have been at any time
since March," she said.

Britain has administered more than a million COVID-19
vaccines - more than the rest of Europe put together, Health
Secretary Matt Hancock said, declaring it a triumph of British
science.

Johnson's government has secured 100 million doses of the
Oxford/AstraZeneca vaccine which can be stored at fridge
temperatures between two to eight degrees, making it easier to
distribute than the Pfizer shot.

Six hospitals in England are administering the first of
around 530,000 doses Britain has ready. The programme will be
expanded to hundreds of other British sites in coming days, and
the government hopes it will deliver tens of millions of doses
within months.

The U.S. Centers for Disease Control and Prevention said it
had administered 4.2 million first doses of COVID-19 vaccines as
of Saturday morning and distributed 13.07 million doses.

More than a tenth of Israel's population have had a vaccine
and it is now administering more than 150,000 doses a day.

Germany and Denmark are looking into the possibility of
delaying administering a second dose of the Pfizer vaccine to
make scarce supplies go further, after a similar move by
Britain.

Britain became the first Western country to approve and roll
out a COVID-19 vaccine, although it is behind Russia and China
which have been inoculating their citizens for months.
(Additional reporting by Elizabeth Piper, Writing by William
James, Guy Faulconbridge and Alistair Smout; Editing by Kate
Holton, Nick Macfie and Mike Collett-White)

More News
25 Apr 2024 09:12

LONDON MARKET OPEN: Anglo American jumps on takeover bid from BHP

(Alliance News) - Stock prices in London opened mixed on Thursday, as investors cautiously eye data on the health of the US economy.

Read more
25 Apr 2024 08:38

AstraZeneca blows past analysts' estimates for Q1

(Sharecast News) - AstraZeneca posted better-than-expected revenues and profit for the first quarter of 2024 with both the company and analysts highlighting its drug pipeline.

Read more
25 Apr 2024 07:56

REPEAT: Miner Anglo American reviews takeover bid from rival BHP

(Alliance News) - Stocks in London are called to open slightly higher, after a busy start to the day, with corporate earnings and updates.

Read more
25 Apr 2024 07:52

Sanofi profit slips on generic competition and currency effects

April 25 (Reuters) - Sanofi's first-quarter operating income fell 14.7% as currency effects and cheap competition to its multiple sclerosis drug Aubagio outweighed rising sales of anti-inflammatory drug Dupixent, the French drugmaker said on Thursday.

Read more
25 Apr 2024 07:43

LONDON BRIEFING: Miner Anglo American eyes rival BHP takeover

(Alliance News) - Stocks in London are called to open slightly higher, after a busy start to the day, with corporate earnings and updates.

Read more
25 Apr 2024 06:30

Sanofi Q1 profit slips on generic competition, forex effects

April 25 (Reuters) - Sanofi's said on Thursday first-quarter operating income declined 14.7% as unfavourable currency effects and cheap competition to multiple sclerosis drug Aubagio outweighed rising sales of anti-inflammatory drug Dupixent.

Read more
24 Apr 2024 10:32

Angle shares jump on supplier agreement with with AstraZeneca

(Alliance News) - Angle PLC shares rose on Wednesday, after it signed a contract with AstraZeneca PLC.

Read more
24 Apr 2024 10:10

AIM WINNERS & LOSERS: Filtronic jumps as lifts outlook

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
18 Apr 2024 14:17

UK earnings, trading statements calendar - next 7 days

Friday 19 April 
888 Holdings PLCTrading Statement
Man Group PLCTrading Statement
Monday 22 April 
Brave Bison Group PLCFull Year Results
Elixirr International PLCFull Year Results
Frenkel Topping Group PLCFull Year Results
Mobico Group PLCFull Year Results
South32 LtdQ3 Results
Ten Lifestyle Group PLCHalf Year Results
Tuesday 23 April 
Alliance Pharma PLCFull Year Results
Alphawave IP Group PLCFull Year Results
Anglo American PLCTrading Statement
ASA International Group PLCFull Year Results
Associated British Foods PLCHalf Year Results
Eleco PLCFull Year Results
GB Group PLCTrading Statement
Jupiter Fund Management PLCTrading Statement
Maintel Holdings PLCFull Year Results
Property Franchise Group PLCFull Year Results
Taylor Wimpey PLCTrading Statement
tinyBuild IncFull Year Results
Trellus Health PLCFull Year Results
Wednesday 24 April 
1Spatial PLCFull Year Results
abrdn PLCTrading Statement
Ecora Resources PLCTrading Statement
Fresnillo PLCTrading Statement
Lloyds Banking Group PLCQ1 Results
Nichols PLCTrading Statement
PensionBee Group PLCFirst Quarter Results
PZ Cussons PLCTrading Statement
Reckitt Benckiser Group PLCTrading Statement
Sanderson Design Group PLCFull Year Results
Serica Energy PLCFull Year Results
Star Energy Group PLCFull Year Results
Tortilla Mexican Grill PLCFull Year Results
Tracsis PLCHalf Year Results
Warpaint London PLCFull Year Results
Thursday 25 April 
Aquila European Renewables PLCFull Year Results
Argo Blockchain PLCFull Year Results
AstraZeneca PLCQ1 Results
Barclays PLCQ1 Results
Checkit PLCFull Year Results
Coca-Cola Europacific Partners PLCTrading Statement
Destiny Pharma PLCFull Year Results
Hikma Pharmaceuticals PLCTrading Statement
Focusrite PLCHalf Year Results
Ibstock PLCTrading Statement
Inchcape PLCTrading Statement
J Sainsbury PLCFull Year Results
London Stock Exchange Group PLCQ1 Results
Persimmon PLCTrading Statement
PPHE Hotel Group LtdTrading Statement
PureTech Health PLCFull Year Results
Relx PLCTrading Statement
Renewi PLCTrading Statement
Schroders PLCQ1 Results
Skillcast Group PLCFull Year Results
Travis Perkins PLCTrading Statement
Trifast PLCTrading Statement
Unilever PLCQ1 Results
WAG Payment Solutions PLCTrading Statement
Weir Group PLCTrading Statement
WH Smith PLCHalf Year Results
WPP PLCTrading Statement
Zinc Media Group PLCFull Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
16 Apr 2024 09:48

LONDON BROKER RATINGS: RBC raises Admiral; Barclays cuts Phoenix Group

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
16 Apr 2024 09:30

Boehringer replaces Bayer as Germany's largest drugmaker on Jardiance gains

INGELHEIM, Germany, April 16 (Reuters) - Boehringer Ingelheim on Tuesday overtook Bayer as Germany's largest drugmaker when the unlisted company reported a currency-adjusted gain in 2023 pharmaceutical sales of 10.3% to 20.8 billion euros ($22.11 billion).

Read more
16 Apr 2024 08:39

AstraZeneca's hails Imfinzi survival data on cancer form

(Alliance News) - AstraZeneca PLC on Tuesday said that its immunotherapy Imfinzi showed positive survival rate in people with advanced biliary tract cancer.

Read more
12 Apr 2024 12:55

EU regulator rules out link between weight-loss drugs and suicidal thoughts

April 12 (Reuters) - The European Union drug regulator found no evidence that a class of diabetes and weight-loss drugs such as Novo Nordisk's hugely popular Wegovy, are linked to suicidal thoughts, it said on Friday, ending a nine-month probe.

Read more
11 Apr 2024 18:51

AstraZeneca CEO could earn 19 million pounds as pay measure clears opposition

Policy approved with two-third of votes in favour

*

Read more
11 Apr 2024 17:13

FTSE 100 edges lower as financials drag

Lok'nStore surges to all-time high after buyout by Shurgard

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.